Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
Spotlight on Kristen Ruisi—Protecting Intellectual Property in Celebrity Endorsement Deals
Spotlight on Kristen Ruisi—Protecting Intellectual Property in Celebrity Endorsement Deals
March 21, 2023
5min
Tips for Accused Infringers Amid Uptick in Streaming Media Patent Litigation
Tips for Accused Infringers Amid Uptick in Streaming Media Patent Litigation
February 28, 2023
1min
Adidas Stripe TM Trial Loss Hinged on Price Points
Adidas Stripe TM Trial Loss Hinged on Price Points
February 27, 2023
1min
Events
The Power Duo: How AI and Web3 are Shaping the Future of Business
The Power Duo: How AI and Web3 are Shaping the Future of Business
March 31, 2023 Miami NFT Week
Recent News
Venable to Provide IP and Legal Counsel Services to Mobile Global Esports, the Company Driving Competitive University Esports in India
Venable to Provide IP and Legal Counsel Services to Mobile Global Esports, the Company Driving Competitive University Esports in India
March 23, 2023
3min
Executive Alliance Names Venable to Its Honor Roll Award for Women’s Representation
Executive Alliance Names Venable to Its Honor Roll Award for Women’s Representation
March 22, 2023
1min
Venable Client Nelstone Ventures Leads Allermi Seed Round with $3.4 Million Investment
Venable Client Nelstone Ventures Leads Allermi Seed Round with $3.4 Million Investment
March 20, 2023
1min